Hong Kong · Clinics, agencies, contracts and payments

Hong Kong surrogacy: clinics, agencies, contracts and payment risks

Hong Kong surrogacy: clinics, agencies, contracts and payment risks

What can lawfully be arranged?

Hong Kong does not operate a general market in paid surrogacy. A non-commercial arrangement can be contemplated within the Human Reproductive Technology Ordinance (Cap. 561), but only within its strict limits; an agency's glossy offer, a clinic's IVF licence or a signed contract is not proof that a particular programme is lawful. Four separate questions must be checked before paying: whether the medical procedure and participants qualify, whether the centre is specifically authorized for surrogacy, whether each payment falls within the law, and how the child could acquire legal parentage. This article addresses Hong Kong-facing clinic, intermediary, contract and payment decisions; it does not certify a particular provider or replace advice on another country involved. [S1] [S3] [S4]

Section 17 of Cap. 561 prohibits making or receiving payment, in Hong Kong or elsewhere, for initiating or taking part in negotiations toward a surrogacy arrangement, offering to negotiate it, or compiling information for use in making or negotiating arrangements. It also addresses recruitment for prohibited activities, managing businesses carrying them out, and knowingly advancing arrangements affected by prohibited paid negotiation. Section 17(2) separately prohibits publication or distribution of advertisements relating to surrogacy arrangements, even where the advertisement does not expressly invite paid conduct. Thus a matching fee, candidate database subscription, commission, referral package or promotional campaign needs specific legal scrutiny; renaming a fee 'consulting' does not settle its character. The territorial reach and application to particular overseas actors require specialist analysis rather than an assumed safe offshore loophole. A published legal analysis argues that section 17(1) targets paid negotiations and information-gathering, not necessarily every direct payment for carrying a pregnancy. That interpretation is scholarly, not a binding judicial clearance or a safe loophole: the separate advertising ban, parental-order payment test and other legal risks remain. Do not treat direct payment as permitted without independent advice on the actual facts. [S1] [S4] [S10]

Licensing and who qualifies

Under section 13, reproductive technology activities require a Council on Human Reproductive Technology (CHRT) licence. Section 19 makes clear that a licence cannot authorize conduct contrary to sections 14–17. Check the CHRT's live licence register, the exact premises and licence holder, the class and conditions of the licence, and express permission for surrogacy as a specified activity. A treatment licence authorizing ordinary IVF is not automatic surrogacy authorization. A government reply dated 24 May 2023 stated that none of the then licensed treatment centres was authorized for surrogacy; that dated snapshot must not be presented as a verified 2026 availability statement. Obtain current written confirmation from the CHRT and the proposed centre before assuming a Hong Kong treatment pathway exists. [S1] [S5] [S6]

Section 14 of Cap. 561 requires that gametes used for a Hong Kong-law surrogacy arrangement belong to the two parties to a marriage who commission it: donor eggs or sperm cannot simply be substituted. The CHRT Code of Practice effective 1 December 2025 further limits the procedure to a case where the wife cannot carry a pregnancy to term and no other treatment option is practicable. This is a clinical condition needing reasoned documentation, not a lifestyle preference or a guarantee of acceptance. Section 15(5) generally restricts provision of reproductive technology to married persons, subject to express exceptions including a procedure provided to a surrogate under a qualifying arrangement. That exception does not make unmarried commissioning clients or donor-gamete surrogacy eligible. [S1] [S3] [S4]

Surrogate safeguards and permissible costs

Chapter XII of the 2025 Code requires appropriate assessment of the proposed surrogate by a registered medical practitioner independent of the doctors performing the reproductive technology procedure. Considerations include her marital status, previous pregnancies, and physical and psychological suitability; higher pregnancy risk weighs against selection. The Code says a woman under 21 must not act as surrogate and calls for her consent and, if she is married, her husband's consent. The licensed centre must provide multidisciplinary counselling to the commissioning couple, surrogate and her husband if applicable, including medical, family-law and social dimensions. Assessment must prioritize the future child's welfare. These are provider obligations and safeguards, not a promise that a candidate who signs a form will be accepted. The Code describes a team including two non-attending doctors who recommended the arrangement, a family-law adviser and a medical social worker, with a psychologist where appropriate. Recommendations and reasons for counselling must be recorded. An agency sales call is not a substitute for the licensed centre's process. [S3]

Payment analysis starts with the statutory definition, not the agency's invoice heading. Section 2 of Cap. 561 excludes from 'payment', for a surrogacy arrangement, reimbursement or defraying of the surrogate's expenses for a reproductive technology procedure and bona fide medical expenses arising from pregnancy and delivery. This is a narrow definition, not blanket permission for living allowances, inconvenience payments, profit, wages, accommodation packages or intermediary commissions. The precise payer, recipient, purpose, evidence and economic substance matter. Section 12(7) of the Parent and Child Ordinance (Cap. 429) also creates a distinct parental-order scrutiny of money or benefits, other than reasonably incurred expenses, with a possible court authorization or subsequent approval. Satisfying one test does not automatically satisfy the other. [S1] [S2]

Payment red flags and contract enforcement

A useful payment check separates four categories. First, directly invoiced licensed clinical treatment: verify the authorized medical service, patient and clinic, and contractual refund terms; a medical bill does not itself authorize surrogacy. Second, the surrogate's documented reproductive-procedure and genuine pregnancy/delivery medical expenses: assess against the statutory exclusion, supporting invoices and payee. Third, matching, arranging, negotiating, advertising or compiling surrogate information for reward: section 17 presents a serious prohibition risk even if billed abroad. Fourth, cash 'compensation', success bonuses, flat allowances and bundled international packages: do not characterize these as automatically permitted medical costs. Ask for a line-by-line invoice and independent legal classification before transferring funds; no single fixed lawful price can be inferred from the Ordinance. [S1] [S2]

Section 18 of Cap. 561 provides that no surrogacy arrangement is enforceable by or against the people who made it. A document signed by all parties therefore cannot compel a surrogate to hand over a child, an intended parent to assume parentage, or performance of the surrogacy promise. This statutory rule does not by itself decide every separate dispute about a clinic's services, a law firm's engagement or return of a deposit; those require identification of the actual agreement, governing law, severability, restitution and any illegality. Avoid drafting a 'guaranteed baby', automatic custody, forced medical treatment or non-refundable matching fee clause as though signatures cure the underlying risk. Consent must remain meaningful throughout clinical decisions. [S1] [S4]

Documents and legal parentage

Separate documents by function. For the clinic, obtain its licence evidence, individualized treatment plan, medical risk disclosures, counselling records, informed medical consents and itemized fee/refund policy. For the surrogate and commissioning couple, record identity, marriage where relevant, gamete origin, medical suitability, independent advice and the Code's surrogacy consent process; Annex II includes Consent Form 12. For an intermediary, demand the identity of the contracting entity, exactly what it will do, the legal basis for any charge, the destination of funds, advertising practices and cancellation conditions. Written records help prove facts but do not validate prohibited activities or turn an unenforceable surrogacy arrangement into an enforceable one. [S3] [S7]

Legal parentage is different from who paid or supplied genetic material. Under section 9 of Cap. 429, the woman who carries the child is initially its legal mother, including where the embryo transfer occurred outside Hong Kong. A father may be determined under section 10 depending on marriage, consent and treatment circumstances. Section 12 provides a possible parental order for a married commissioning husband and wife; the statutory framework includes a link through at least one spouse's gametes, an application within six months of birth, the child's home and Hong Kong connection, and age and consent conditions. The surrogate's consent for this purpose is ineffective if given less than six weeks after birth. The court also examines payments. Neither genetics, a foreign birth certificate nor a contract automatically supplies a Hong Kong parental order. Although section 12(2) specifies six months, Hong Kong decisions including FH & MH v WB & HB (2019) and HSC v T (2026) have allowed extensions after considering the child's welfare, the delay and other case-specific factors. An extension is not automatic: seek immediate advice about applying with an extension request if late. The court also requires informed unconditional agreement from the surrogate and any other legal father, unless a statutory consent exception applies because the person cannot be found or cannot give consent; both applicants must be at least 18. More precisely, both when the application is made and when the order is granted, the child's home must be with at least one applicant. At least one spouse must be domiciled in Hong Kong, have been habitually resident there throughout the immediately preceding year, or have a substantial connection with Hong Kong; a merely incidental tie is not enough. [S2] [S4] [S11]

Cross-border checks and prepayment diligence

For a proposed treatment or birth abroad, analyse two legal systems before contracting, not only the jurisdiction named on an invoice. Hong Kong's section 17 expressly refers to paid arranging activity 'whether in Hong Kong or elsewhere', while sections 9 and 12 of Cap. 429 may be relevant to a child carried abroad. The destination state's rules may separately govern clinical practice, surrogate consent, birth registration, nationality, travel documents, immigration and recognition of any foreign judgment. An overseas programme marketed to Hong Kong residents is not therefore immune from Hong Kong legal risks. Check each person's nationality, domicile or habitual residence, marriage, gamete sources, proposed place of treatment and birth, and intended place of family residence with counsel qualified in both jurisdictions. [S1] [S2]

Before sending a deposit, ask for the actual CHRT licence terms or official confirmation of applicable authorization; a written explanation of the couple's and surrogate's eligibility; separate clinic, agency and medical expense contracts; all beneficiaries' legal names and bank accounts; a dated line-item budget with documentary support; cancellation and failed-cycle rules; data-handling safeguards; and a post-birth parentage plan. Ask who holds money while conditions are unfulfilled, which payments can be independently refunded, how unexpected maternal complications are funded and what happens if the surrogate withdraws consent. Do not disclose sensitive medical documents to an unidentified recruiter. Obtain independent Hong Kong medical and family-law review before signing, not just a sales representative's assurance. [S3] [S6] [S7]

Two practical scenarios and action after payment

Consider an offer to 'find a surrogate', collect a substantial matching fee, transfer the balance to a foreign provider and guarantee a parental order. The matching service raises section 17 concerns; the clinic's general IVF licence says nothing about a surrogacy-specific authorization; the promised transfer of the child cannot be enforced under section 18; and parental status depends on a subsequent court process and facts not yet established. A non-commercial family acquaintance arrangement avoids one obvious commercial feature but still requires participant eligibility, medical safeguards and lawful licensing; it does not bypass section 18. In both cases the correct decision is evidence-led due diligence, not treating a signed package as regulatory clearance. [S1] [S2] [S3]

If funds have already been paid or treatment has started, preserve proposals, advertisements, chats, bank records, invoices, consent documents and clinical records. Do not assume that threatening to enforce the surrogacy contract or withholding care will solve the problem. A Hong Kong lawyer should classify the transfers and counterparties, assess potential regulatory or criminal exposure, and examine any separate claim for reimbursement or misrepresentation without promising recovery. Report suspected unauthorized reproductive technology to the CHRT and seek appropriate law-enforcement advice where indicated; clinical safety and the child's interests remain immediate priorities. If birth is approaching, urgently obtain specialist family-law advice on section 12 time limits, consents and evidence. Nothing in this article establishes a provider's current licence, transaction legality or right to a court order. [S1] [S2] [S6]

Sources and legal references

  1. Human Reproductive Technology Ordinance, Cap. 561 (accessible law-text reproduction) (S1)
  2. Parent and Child Ordinance, Cap. 429 (accessible law-text reproduction) (S2)
  3. CHRT Code of Practice on Reproductive Technology and Embryo Research (December 2025) (S3)
  4. CHRT patient FAQ on surrogacy (S4)
  5. Hong Kong Government legislative reply 24 May 2023 (S5)
  6. CHRT list of licensed centres (S6)
  7. CHRT information required for patients (S7)
  8. Cheung and Wan, Hong Kong’s failed attempt at criminalising commercial surrogacy, Medical Law International (2025/2026) (S10)
  9. HSC v T [2026] HKCFI 770, case analysis (Bernacchi Chambers) (S11)

Last updated:

Author: Khachatrian Razmik, LL.M.

International surrogacy and parentage legal services — LEX SURROGACY by Lex Agency · Author profile · Editorial standards